Cargando…
Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: A case report
RATIONALE: Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease caused by a cytosine, guanine, thymine (CTG) trinucleotide repeat expansion in the non-coding region of dystrophia myotonica protein kinase gene, causing a multisystem involvement. To date, few studies have been performed to...
Autores principales: | Portaro, Simona, Naro, Antonino, Guarneri, Claudio, Di Toro, Giuseppe, Manuli, Alfredo, Calabrò, Rocco Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283126/ https://www.ncbi.nlm.nih.gov/pubmed/30508964 http://dx.doi.org/10.1097/MD.0000000000013448 |
Ejemplares similares
-
Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity
por: Portaro, Simona, et al.
Publicado: (2017) -
Overground exoskeletons may boost neuroplasticity in myotonic dystrophy type 1 rehabilitation: A case report
por: Portaro, Simona, et al.
Publicado: (2019) -
Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks
por: Naro, Antonino, et al.
Publicado: (2019) -
How Covid 19 has changed Neurorehabilitation in Italy: a critical appraisal
por: Calabrò, Rocco Salvatore, et al.
Publicado: (2020) -
A Case-Controlled Pilot Study on Rhythmic Auditory Stimulation-Assisted Gait Training and Conventional Physiotherapy in Patients With Parkinson's Disease Submitted to Deep Brain Stimulation
por: Naro, Antonino, et al.
Publicado: (2020)